Intelligent Investor

Starpharma Holdings Limited (ASX: SPL) - Announcements

Current share price for SPL : $0.125 0.01 (7.41%)

ASX company news and announcements for Starpharma Holdings Limited (SPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Starpharma Holdings Limited (SPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Starpharma Holdings Limited (SPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Starpharma Holdings Limited (SPL)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$52 DNT Inc - New Patents granted/Recieves add grant funding 18 Nov 2003 3:46PM $0.590 $0.125 $0.130 fallen by 78.81%
$52 US award for Starpharma Associate DNT Inc 8 Oct 2003 12:31PM $0.630 $0.125 $0.130 fallen by 80.16%
$52 Preliminary Final Report 11 Sep 2003 2:23PM $0.630 $0.125 $0.130 fallen by 80.16%
$52 Placement 10 Sep 2003 9:39AM $0.600 $0.125 $0.130 fallen by 79.17%
$52 Trading Halt 8 Sep 2003 9:39AM n/a $0.125 $0.130 n/a
$52 Trading Halt 8 Sep 2003 9:39AM n/a $0.125 $0.130 n/a

751 - 756 of 756 results

Page 31 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.